Pictet Asset Management (Switzerland)’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $589K | Buy |
10,542
+1,224
| +13% | +$68.3K | ﹤0.01% | 1163 |
|
|
2023
Q1 | $520K | Hold |
9,318
| – | – | ﹤0.01% | 1227 |
|
|
2022
Q4 | $340K | Buy |
+9,318
| New | +$340K | ﹤0.01% | 1420 |
|
|
2022
Q3 | – | Sell |
-209,595
| Closed | -$9.48M | – | 1608 |
|
|
2022
Q2 | $9.48M | Sell |
209,595
-20,141
| -9% | -$911K | 0.01% | 606 |
|
|
2022
Q1 | $17.5M | Sell |
229,736
-35,479
| -13% | -$2.7M | 0.02% | 519 |
|
|
2021
Q4 | $39.5M | Buy |
265,215
+127,422
| +92% | +$19M | 0.04% | 389 |
|
|
2021
Q3 | $20.1M | Buy |
+137,793
| New | +$20.1M | 0.02% | 510 |
|